Senior insider sale
Chief Financial Officer at KESTRA MEDICAL TECHNOLOGIES, LTD. — senior position signals high conviction
$289.9K
12.80K shares
What this filing means
MAHBOOB VASEEM plans to sell 12.80K shares of KESTRA MEDICAL TECHNOLOGIES, LTD. valued at approximately $289.9K. Form 144 is a notice of intent to sell restricted or control securities — not a mandatory transaction. This filing provides advance warning of potential selling pressure.
Filed: 7/31/2026ACC: 0001964306-26-000342
Officer· Chief Financial Officer
Since Mar 2025
12.80K
Shares to sell
$289.9K
Approx. market value
8.82K
Acquired (3 months)
1
Planned
1 completed
Securities Acquired — Last 3 Months1
Vesting of performance share unit awards
Granted as part of issuer equity compensation plan
7/17/2026
8.82KTotal acquired8.82K
| Acquisition Date | Type | Amount Acquired | Gift |
|---|---|---|---|
7/17/2026 | Vesting of performance share unit awards Granted as part of issuer equity compensation plan | 8.82K | — |
| Total | 8.82K | ||
Planned & Completed Dispositions2
Completed
—Completed
Units to sell
3.98K
Market value
$90.6K
7/30/2026
Planned — Approximate Date
NASDAQPlanned
Units to sell
8.82K
Market value
$199.3K
7/31/2026
Total
Units
12.80K
Value
$289.9K
| Date | Units to Sell | Approx. Market Value | Exchange | Status |
|---|---|---|---|---|
| Completed | ||||
7/30/2026 | 3.98K | $90.6K | — | Completed |
| Planned — Approximate Date | ||||
7/31/2026 | 8.82K | $199.3K | NASDAQ | Planned |
| Total | 12.80K | $289.9K | ||